Today’s press release from the Canadian Arthritis Patient Alliance (CAPA) highlights a new report examining the impact of drug shortages on people living with arthritis across Canada. The report, based on interviews with patients and caregivers conducted in 2025, shows how supply disruptions are affecting daily life, with many individuals only learning about shortages at the pharmacy counter. As a result, some are rationing medications, facing uncertainty about future access, and struggling to find suitable alternatives.

It also points to broader system challenges, including poor communication about shortages, limited coordination between healthcare providers and pharmacies, and insurance barriers. CAPA is calling for improved communication, better coordination, and more flexible policies to help reduce the impact on patients.